Kouassi E, Revillard J P
Laboratoire d'Immunologie INSERM U80 UA CNRS 1177, Lyon, France.
Eur J Pharmacol. 1987 Nov 24;144(1):97-100. doi: 10.1016/0014-2999(87)90014-8.
The receptors involved in the cyclic adenosine 3',5'-monophosphate (cAMP)-increasing action of dopamine (DA) in mouse lymphoid cells were determined by comparing the potencies of specific DA receptor and adrenoceptor antagonists to inhibit the cAMP response to DA and to isoproterenol. The beta-adrenoceptor antagonists propranolol, pindolol and dichloroisoproterenol were the most potent inhibitors of the response to both DA and isoproterenol. Their potencies were 2-3 orders greater for the inhibition of DA than isoproterenol action. SCH 23390 (selective DA1 antagonist) and haloperidol (mixed DA1/DA2 antagonist) inhibited the DA action only at high concentrations (10(-5)-10(-4) M) which did not affect the response to isoproterenol. These results indicate that beta-adrenoceptors are involved in the DA-induced elevation of mouse lymphocyte cAMP.
通过比较特定多巴胺(DA)受体拮抗剂和肾上腺素能受体拮抗剂抑制小鼠淋巴细胞中对DA和异丙肾上腺素的环磷酸腺苷(cAMP)反应的效力,确定了参与DA增加小鼠淋巴细胞中cAMP作用的受体。β-肾上腺素能受体拮抗剂普萘洛尔、吲哚洛尔和二氯异丙肾上腺素是对DA和异丙肾上腺素反应最有效的抑制剂。它们对DA抑制作用的效力比对异丙肾上腺素作用的效力高2至3个数量级。SCH 23390(选择性DA1拮抗剂)和氟哌啶醇(混合DA1/DA2拮抗剂)仅在高浓度(10⁻⁵ - 10⁻⁴ M)时抑制DA作用,而这并不影响对异丙肾上腺素的反应。这些结果表明,β-肾上腺素能受体参与了DA诱导的小鼠淋巴细胞cAMP升高。